News

EyePoint Pharmaceuticals to Present at Notable Investor Events

EyePoint Pharmaceuticals to Present at Notable Investor Events

EyePoint Pharmaceuticals to Showcase at Upcoming Conferences

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company dedicated to developing groundbreaking therapeutics for serious retinal diseases, has announced its management's participation in several upcoming investor conferences. These events provide a platform for the company to engage with potential investors and stakeholders about its innovative pipeline.

Details of Upcoming Conferences

Guggenheim's Inaugural Healthcare Innovation Conference

This conference will feature a fireside chat with EyePoint's management on Monday at 2:00 p.m. ET. It represents a significant opportunity for the company to discuss its advancements and future prospects.

UBS Global Healthcare Conference

Scheduled for Wednesday at 1:15 p.m. PT, this event will also include a fireside chat, allowing the company to connect meaningfully with healthcare investors and analysts.

Jefferies London Healthcare Conference

This corporate presentation will take place on Tuesday at 8:00 a.m. GMT, where EyePoint will provide insights into its innovative drug delivery technologies and future clinical trials.

BTIG 4th Annual Ophthalmology Day

On Monday at 10:00 a.m. ET, management will participate in a fireside chat, further highlighting the company's commitment to advancing its therapeutic options.

EyePoint's Innovative Pipeline

EyePoint Pharmaceuticals utilizes its proprietary Durasert E™ technology to enhance intraocular drug delivery. The lead product, DURAVYU™ (previously known as EYP-1901), is currently undergoing pivotal Phase 3 clinical trials targeting wet age-related macular degeneration (AMD) and a Phase 2 trial for diabetic macular edema (DME). These conditions profoundly impact the vision of individuals over 50 years old, and EyePoint is focused on delivering effective treatment options.

Progress and Expectations

EyePoint anticipates topline data from its Phase 2 trial for DME in the first quarter of 2025. Additionally, topline results from the Phase 3 trials for wet AMD are expected in 2026. This timeline marks a crucial milestone for the company as it prepares to make significant contributions to ophthalmic treatments.

The Technology Behind EyePoint

The Durasert® technology has been validated through multiple FDA-approved products and has shown a favorable safety profile across thousands of administrations in patients. This established technology positions EyePoint well within the biopharmaceutical landscape.

About EyePoint Pharmaceuticals

Headquartered in Watertown, Massachusetts, EyePoint Pharmaceuticals is a clinical-stage biopharmaceutical company committed to developing therapies that improve patients' lives. The company is innovative in its approach and aims to address significant unmet needs in treating severe retinal diseases.

Company Contact Information

For further inquiries, please contact:

Investors:

Christina Tartaglia
Precision AQ (formerly Stern IR)
Direct: 212-698-8700
Email: christina.tartaglia@precisionaq.com

Media Contact:

Amy Phillips
Green Room Communications
Direct: 412-327-9499
Email: aphillips@greenroompr.com

Frequently Asked Questions

What is the significance of EyePoint's participation in these conferences?

EyePoint's participation in these conferences allows the company to engage with potential investors and share insights on its innovative therapies.

What is DURAVYU™?

DURAVYU™ (formerly EYP-1901) is an investigational therapeutic designed for sustained delivery in treating VEGF-mediated retinal diseases.

What clinical trials is EyePoint currently conducting?

EyePoint is conducting Phase 3 trials for wet AMD and Phase 2 trials for DME, both critical conditions affecting vision.

Where is EyePoint Pharmaceuticals located?

EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.

How can investors learn more about EyePoint's upcoming presentations?

Investors can access the webcast and archived replays of the presentations through the Investors section of the company website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

SeaWorld Rings in Holidays with All-New Festivities

Updated Category News Views 47

Holiday Transformation at SeaWorld's Parks The holiday spirit isn't something you purchase—it’s an experience. And boy, SeaWorld seems to get this right. As the chill of late October settles in, SeaWorld parks across Orlando, San Diego, and San Antonio start dressing up for the holiday season, morphing into a spectacle of lights and festive joy. For anyone who’s...

Continue Reading
JOIA Rose Hall Revives Jamaican Luxury Experience

Updated Category News Views 94

A New Chapter for Jamaican Luxury If there's one thing that gets the blood pumping, it's a massive overhaul of a decades-old resort, especially one sitting pretty on Montego Bay's golden shores. December 1, 2026, marks the return of JOIA Rose Hall to the hospitality scene—shiny, revamped, and all about delivering an oasis fueled by authentic Jamaican culture. Forget...

Continue Reading
LanguageLine AI App Earns Vizient Technology Kudos

Updated Category News Views 57

Tech Talk: LanguageLine's AI App Gains Important Recognition Diving headfirst into the chaotic world of healthcare, LanguageLine's AI Translation App earned a standout accolade. Just announced, it's snagged the Innovative Technology Designation from Vizient, the heavyweight champ in healthcare performance improvement. On the scene since the end of October, they rolled the...

Continue Reading
ACACIA's Big Move with Bel-Mac and Seashore: Will It Pay Off?

Updated Category News Views 57

A New Powerhouse in Roofing Services? Take a seat, folks—we're talking about a regional shakeup in the world of roofing and exterior building. ACACIA Exterior Building Group, based out of Alexandria, Virginia, just tightened its grip on the Mid-Atlantic and Gulf Coast markets by investing in Bel-Mac Roofing and Seashore Construction. This ain't just your run-of-the-mill...

Continue Reading
Thunderly Bags Davey Awards for Creative Franchise Videos

Updated Category News Views 87

Big Wins from Humble Beginnings Ever notice how some small outfits have a knack for punching above their weight? Thunderly, a Dallas-based marketing agency, is a shining example of that. They've just snagged two Silver Awards at the 22nd Annual Davey Awards—and it’s stirring up talk across the sector. Winning a Davey isn’t child's play; it’s about small teams...

Continue Reading
Bitcoin Mortgages: APX Ushers in New Canadian Era

Updated Category News Views 75

Bitcoin Meets Canadian Mortgages: A Game Changer? Here's a scenario you didn't see coming: Bitcoin, the digital darling of the new millennium, now backing Canadian mortgages. If that doesn't get your financial senses tingling, maybe you haven't been paying attention. APX Lending, a pioneer in digital-asset-backed lending, is kicking open the doors to a fresh financial...

Continue Reading
McKay Brothers Enhances Fastest Routes for Market Data

Updated Category News Views 118

Breaking Down McKay Brothers' Latest Maneuver Yeah, the financial market isn't just numbers and screens—it's about moving those numbers faster than a cheetah chasing prey. McKay Brothers knows this game inside and out, and they're laying down new wires, or rather, wireless, to make sure they've got the quickest routes in the room. Let me tell you, they're throwing money...

Continue Reading
Virax Biolabs Expands China Reach With Key Partnerships

Updated Category News Views 68

Virax Biolabs' Strategic Play in China Does Virax Biolabs have a trick up its sleeve, or is it just rolling the dice in the vast Chinese market? With three new distributor agreements, it sure seems like it's trying to tip the scales in its favor. The London-based company announced new distribution agreements for its ImmuneSelect research-use immune profiling products....

Continue Reading
Frontera Energy's Q3 Results Call: Key Insights Ahead

Updated Category News Views 107

What to Expect from Frontera’s Upcoming Call Frontera Energy’s got a date with the earnings table, and it’s set for November 11. The story here is about anticipation, folks. This Canadian energy player will lay its third-quarter results bare soon as trading wraps up. They’ll be breaking the nitty-gritty down in a call with the analysts that follows the next day,...

Continue Reading
FirstEnergy Bolsters Support for Shelter Initiatives

Updated Category News Views 80

FirstEnergy Foundation's Commitment Shines Bright Alright, here's the scoop. FirstEnergy Foundation isn't just about keeping the lights on anymore. They're throwing down $620,000 to tackle one hell of a tough nut—shelter and stability. This latest infusion spreads across five states, with ten nonprofit warriors in New Jersey alone locking in $120,000 of that pot for...

Continue Reading

Top 5 Most Recently Viewed Articles

Catholic Colleges Excel in AI Readiness, Study Shows

Updated Category News Views 12

Faith and Tech: An Unexpected Alliance? Alright, here's something that'll make you sit up: Catholic college grads are not just busy sipping their morning coffee while they muse over moral philosophy—they're out there on the front lines of artificial intelligence, better prepared and more engaged than their peers from secular schools. According to the latest Holistic...

Continue Reading
Analyzing Ferguson Enterprises' Market Trends and Movements

Updated Category News Views 224

Understanding Ferguson Enterprises' Market Dynamics Ferguson Enterprises Inc (NYSE: FERG) has seen notable fluctuations in its market activities recently. Specifically, the company's short percent of float has recorded a rise of 12.66% according to the latest available data. Presently, there are approximately 3.12 million shares sold short, which constitutes about 1.78%...

Continue Reading
Howard Community College Excels with Aspen Prize Nomination

Updated Category News Views 163

Howard Community College’s Outstanding Achievement Howard Community College (HCC) has garnered national recognition by being selected as one of only 200 community colleges across the country eligible to compete for the esteemed 2027 Aspen Prize for Community College Excellence. Offered by the Aspen Institute, this prestigious accolade recognizes high achievement and...

Continue Reading
Innovative AI Collaboration Between Honeywell and TotalEnergies

Updated Category News Views 168

Enhancing Refinery Operations with AI Honeywell International Inc. (NASDAQ: HON) has embarked on an exciting journey with TotalEnergies SE (NYSE: TTE) to innovate the way refinery operations are managed. This collaboration aims to integrate cutting-edge artificial intelligence into the refining process, taking a significant step towards optimizing efficiency and safety in...

Continue Reading
Vivos Therapeutics Secures $3.5 Million Through Stock Offering

Updated Category News Views 249

Vivos Therapeutics Secures $3.5 Million Through Stock Offering Vivos Therapeutics, Inc. (NASDAQ: VVOS), a pioneering medical device company, recently announced an exciting opportunity that solidifies its place in the market for sleep-related treatments. By entering into definitive agreements for a registered direct offering, the company aims to raise $3.5 million. This...

Continue Reading